Log in to save to my catalogue

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival i...

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3046516711

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis

About this item

Full title

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis

Publisher

England: BMJ Publishing Group Ltd

Journal title

International journal of gynecological cancer, 2024-06, Vol.34 (6), p.906-918

Language

English

Formats

Publication information

Publisher

England: BMJ Publishing Group Ltd

More information

Scope and Contents

Contents

ObjectivesCirculating tumor DNA (ctDNA) is emerging as a potential prognostic biomarker in multiple tumor types. However, despite the many studies available on small series of patients with ovarian cancer, a recent systematic review and meta-analysis is lacking. The objective of this study was to determine the association of ctDNA with progression-...

Alternative Titles

Full title

Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_3046516711

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_3046516711

Other Identifiers

ISSN

1048-891X,1525-1438

E-ISSN

1525-1438

DOI

10.1136/ijgc-2024-005313

How to access this item